Bicycle Therapeutics (BCYC) EBT Margin (2018 - 2026)
Bicycle Therapeutics (BCYC) posted EBT Margin of 6837.99% for Q1 2026, down 1687.46% on a QoQ basis from 430.75% in Q4 2025, and down 621816.0% year-over-year from N/an in Q1 2025.
Bicycle Therapeutics (BCYC) EBT Margin (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' EBT Margin history runs 9 years deep, the most recent figure standing at 6837.99% for Q1 2026.
- Quarterly EBT Margin fell 621816.0% year-over-year to 6837.99% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12.34% (up 82380.0% YoY) and the FY2025 annual result came in at 9.16%, up 50185.0% from the prior year.
- EBT Margin was 6837.99% for Q1 2026 at Bicycle Therapeutics, down from 430.75% in the prior quarter.
- Across five years, EBT Margin topped out at 2517.37% in Q4 2023 and bottomed at 6837.99% in Q1 2026.
- A 5-year average of 970.93% and a median of 619.84% in 2025 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin jumped 290347 bps — and 2026, when it tumbled 621816 bps.
- Bicycle Therapeutics' EBT Margin stood at 386.1% in 2022, then jumped by 752 bps to 2517.37% in 2023, then slumped by 157 bps to 1427.62% in 2024, then soared by 130 bps to 430.75% in 2025, then slumped by 1687 bps to 6837.99% in 2026.
- Business Quant data shows BCYC's EBT Margin at 6837.99% in Q1 2026, 430.75% in Q4 2025, and 501.92% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -6,837.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,837.99% |
| Dec 31, 2025 | 430.75% |
| Sep 30, 2025 | -501.92% |
| Jun 30, 2025 | -2,711.75% |
| Mar 31, 2025 | -619.84% |
| Dec 31, 2024 | -1,427.62% |
| Sep 30, 2024 | -2,027.28% |
| Jun 30, 2024 | -424.07% |
| Mar 31, 2024 | -258.78% |
| Dec 31, 2023 | 2,517.37% |
| Sep 30, 2023 | -889.87% |
| Jun 30, 2023 | -378.35% |
| Mar 31, 2023 | -810.50% |
| Dec 31, 2022 | -386.10% |
| Sep 30, 2022 | -940.30% |
| Jun 30, 2022 | -514.62% |
| Mar 31, 2022 | -724.95% |
| Dec 31, 2021 | -1,174.06% |
| Sep 30, 2021 | -348.33% |
| Jun 30, 2021 | -1,012.49% |